Cathay Biotech Inc.
688065.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Growth | -2.3% | 15.4% | 4.4% | – |
| Cost of Goods Sold | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 36.5% | 27.6% | 33.6% | 16.6% |
| R&D Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| G&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| SG&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Sales & Mktg Exp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Other Operating Expenses | CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Operating Expenses | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| Operating Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 15% | 20.6% | 20.8% | 21.9% |
| Other Income/Exp. Net | CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Pre-Tax Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Tax Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 16.2% | 19.2% | 17.7% | 19.4% |
| EPS | 0.2 | 0.24 | 0.23 | 0.25 |
| % Growth | -16.7% | 4.3% | -8% | – |
| EPS Diluted | 0.2 | 0.24 | 0.23 | 0.25 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Interest Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Depreciation & Amortization | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 18.8% | 20.9% | 28.6% | 9.8% |